Dana-Farber Cancer Institute: all 833 studies

Page 8 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
• Ph II CHOP+Velcade in Mediastinal LBCLTerminatedNCT00361621Phase 2
• Trial of PTK787/ZK 222584 Plus PaclitaxelTerminatedNCT00358163Phase 1
• Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell TransplantationCompletedNCT00355407Not applicable
• CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell TransplantationCompletedNCT00333190Not applicable
• Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLLCompletedNCT00330252Phase 1
• Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00301093Phase 1
• Letrozole in Postmenopausal Women at Increased Risk for Breast CancerStatus unknownNCT00280930Phase 2
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsCompletedNCT00268918Phase 1
• Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung CancerActive, not recruitingNCT00264602Phase 1
• Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaCompletedNCT00258687Phase 1
• Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor MalignanciesCompletedNCT00251407Phase 1
• Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular LymphomaCompletedNCT00251394Phase 2
• Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory LeukemiaCompletedNCT00251368Phase 1
• Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic CancerCompletedNCT00251355Phase 1
• Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerCompletedNCT00230542Phase 2
• Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
• Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesCompletedNCT00215501Phase 1
• Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaCompletedNCT00215462Phase 2
• Computerized Assessment for Patients With CancerCompletedNCT00194493Phase 3
• High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast CarcinomaTerminatedNCT00165581Not applicable
• Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal CancerCompletedNCT00165568Phase 2
• Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural MesotheliomaCompletedNCT00165555Phase 1
• A-protein Levels in Adult and Pediatric Brain Tumor PatientsCompletedNCT00165542
• Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium ThiosulfateCompletedNCT00165516Phase 2
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
• Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00165477Phase 2
• Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerCompletedNCT00165464Phase 2
• A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
• Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based ChemotherapyCompletedNCT00165438
• Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal IrradiationActive, not recruitingNCT00165425Not applicable
• Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's DiseaseCompletedNCT00165412
• Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local TreatmentCompletedNCT00165399Phase 2
• MRI-guided Bone Marrow Biopsies of Prostate Cancer PatientsCompletedNCT00165386Not applicable
• rhEndostatin Protein Involving Pediatric Patients With CancerTerminatedNCT00165373Phase 1
• Prolonged Daily Temozolomide for Low-Grade GliomaCompletedNCT00165360Phase 2
• Protein Tyrosine Kinases (PTK) in Multiple MyelomaCompletedNCT00165347Phase 2
• Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
• Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
• Sildenafil Citrate in Waldenstrom's MacroglobulinemiaCompletedNCT00165295Phase 2
• Mantle Irradiation for Hodgkin's DiseaseCompletedNCT00165269Phase 2
• Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The BreastCompletedNCT00165256Phase 2
• Tangential Radiation Therapy Without Axillary Dissection in Breast CancerCompletedNCT00165243Phase 2
• Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsCompletedNCT00165230Phase 2
• Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00165217Phase 2
• Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic OophorectomyCompletedNCT00165204Phase 2
• Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusCompletedNCT00165191Phase 2
• Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00165178Phase 3
• Counseling Interventions for BRCA 1/2 Cancer Susceptibility TestingCompletedNCT00165152Not applicable
• Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and SarcomasCompletedNCT00165139Phase 2
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial CarcinomaCompletedNCT00165126
• Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With CancerCompletedNCT00165100Not applicable
• Treatment of Childhood Acute Lymphoblastic LeukemiaTerminatedNCT00165087Phase 3
• Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT00153933Phase 1
• Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
• Effects of Exercise Intervention on Insulin Levels in Breast Cancer SurvivorsCompletedNCT00153894Not applicable
• Capecitabine in Women With Operable Breast CancerTerminatedNCT00148720Phase 2
• Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedNCT00148707Phase 2
• Preoperative Cisplatin in Early Stage Breast CancerCompletedNCT00148694Phase 2
• Preoperative Herceptin and Navelbine for Breast CancerCompletedNCT00148681Phase 2
• Educational Interventions for Patients With DCISCompletedNCT00148655Not applicable
• Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
• Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00146601Phase 2
• Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNCT00146549Phase 3
• Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyCompletedNCT00146536
• Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
• Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
• Phase II Study of Campath-1H Antibody to Treat Waldenstrom's MacroglobulinemiaCompletedNCT00142181Phase 2
• Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00142155Not applicable
• Bortezomib (Velcade) in Waldenstrom's MacroglobulinemiaCompletedNCT00142129Phase 2
• Preventing Adverse Drug Events With PatientSiteCompletedNCT00140504Not applicable
• Mifepristone (RU-486) in Androgen Independent Prostate CancerCompletedNCT00140478Phase 2
• Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
• Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
• Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139230Phase 2
• Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer PatientsCompletedNCT00139204Not applicable
• Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate CancerCompletedNCT00139191Not applicable
• Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerCompletedNCT00137852Phase 2
• Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated MesotheliomaCompletedNCT00137826Phase 2
• Avastin and Taxotere for Esophagogastric CancerCompletedNCT00137813Phase 2
• Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer PatientsCompletedNCT00137800Phase 2
• Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine TumorsCompletedNCT00137774Phase 2
• Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic CancerCompletedNCT00137761Phase 2
• Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate CancerCompletedNCT00136487Phase 2/3
• Amifostine for Head and Neck Irradiation in LymphomaCompletedNCT00136474Phase 2
• A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00136461Phase 2
• High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)CompletedNCT00136448Phase 2
• Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous LeukemiaCompletedNCT00136422Phase 1
• A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)CompletedNCT00136409Phase 2
• Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host DiseaseCompletedNCT00136396Phase 1/2
• A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerCompletedNCT00134706Phase 2
• Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate CancerCompletedNCT00134654Phase 2
• Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
• Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00130702Phase 2
• Tarceva and Capecitabine for Pancreatic CancerCompletedNCT00125021Phase 2
• Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerCompletedNCT00123851Phase 2
• Gemcitabine and Cisplatin for Gallbladder and Biliary Tract CancerCompletedNCT00123825Phase 2
• Chemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaCompletedNCT00119730Phase 2
• Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal CancerCompletedNCT00116506Phase 2
• Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate CancerCompletedNCT00116220Phase 3

← Dana-Farber Cancer Institute overview and focus areas